Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

May 30, 2025

Conditions
Healthy
Interventions
OTHER

Sea level

Sea level exposure / sea level exposure combined with microdoses of rHuEPO

OTHER

Altitude

Altitude exposure / altitude exposure Iron metabolism

Trial Locations (1)

2200

University of Copenhagen, Copenhagen

All Listed Sponsors
collaborator

World Anti-Doping Agency

OTHER

collaborator

German Sport University, Cologne

OTHER

collaborator

Universidad de Granada

OTHER

collaborator

Oslo University Hospital

OTHER

lead

University of Copenhagen

OTHER